Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Wolf

Showing results (181-190 of 331) with videos related to

Pageof 34
Sort By:
Immunology and Cell Biology|March 9, 2011
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccineChristina Lutz-Nicoladoni, Stephanie Wallner, Patrizia Stoitzner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2009
The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivoAnna Maria Wolf, Kathrin Eller, Robert Zeiser, et al.
Hematological Oncology|August 7, 2020
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1Sonja Heibl, Veronika Buxhofer-Ausch, Stefan Schmidt, et al.
Neuropsychologia|December 17, 2023
Interhemispheric transfer time correlates with white matter integrity of the corpus callosum in healthy older adultsDavid Riedel, Nicolai Lorke, Tim Fellerhoff, et al.
International Journal of Cancer|June 21, 2026
Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025Martin Griesshammer, Haifa Kathrin Al-Ali, Gabriela M Baerlocher, et al.
International Journal of Cancer|June 21, 2026
The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO)Martin Griesshammer, Haifa Kathrin Al-Ali, Gabriela M Baerlocher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 2010
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppressionKathrin Eller, Dominik Wolf, Julia M Huber, et al.
Leukemia & Lymphoma|October 29, 2013
Medical decision analysis for first-line therapy of chronic myeloid leukemiaUrsula Rochau, Gaby Sroczynski, Dominik Wolf, et al.
International Journal of Cancer|January 27, 2009
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancerAlain G Zeimet, Daniel Reimer, Dominik Wolf, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2010
Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancerAlain G Zeimet, Daniel Reimer, Lukas Schwentner, et al.
Pageof 34

Showing results (181-190 of 331) with videos related to

Sort By:
Pageof 34
Immunology and Cell Biology|March 9, 2011
Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccineChristina Lutz-Nicoladoni, Stephanie Wallner, Patrizia Stoitzner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2009
The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivoAnna Maria Wolf, Kathrin Eller, Robert Zeiser, et al.
Hematological Oncology|August 7, 2020
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1Sonja Heibl, Veronika Buxhofer-Ausch, Stefan Schmidt, et al.
Neuropsychologia|December 17, 2023
Interhemispheric transfer time correlates with white matter integrity of the corpus callosum in healthy older adultsDavid Riedel, Nicolai Lorke, Tim Fellerhoff, et al.
International Journal of Cancer|June 21, 2026
Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025Martin Griesshammer, Haifa Kathrin Al-Ali, Gabriela M Baerlocher, et al.
International Journal of Cancer|June 21, 2026
The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO)Martin Griesshammer, Haifa Kathrin Al-Ali, Gabriela M Baerlocher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 2010
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppressionKathrin Eller, Dominik Wolf, Julia M Huber, et al.
Leukemia & Lymphoma|October 29, 2013
Medical decision analysis for first-line therapy of chronic myeloid leukemiaUrsula Rochau, Gaby Sroczynski, Dominik Wolf, et al.
International Journal of Cancer|January 27, 2009
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancerAlain G Zeimet, Daniel Reimer, Dominik Wolf, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2010
Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancerAlain G Zeimet, Daniel Reimer, Lukas Schwentner, et al.
Pageof 34